RSS

controlled release

A white paper entitled ‘Abuse Deterrence for the Pharmaceutical Market?’ has been published by materials technology company Lucideon. more

News

Dow Pharma’s ‘Controlled Release Alliance’ with Colorcon is planning global commercial availability of its Methocel DC2 polymer by year end. more

Technology

Celanese presents a poster session entitled “Predictive Modeling and Validation of Tamoxifen Release from EVA Copolymers.” more

Dow Pharma & Food Solutions, a business unit of The Dow Chemical Company, and Colorcon Inc. presented the next-generation METHOCEL DC2 polymer at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Expo in San Antonio... more

Technology

Colorcon and Evonik Industries have signed a cooperation agreement for the marketing and technical support of Acryl-EZE, an aqueous acrylic enteric system. more

Technology

Head of Cargill's alginates business reveals $15m plant investment strategy

This month I spoke to Bente Korsgaard, Head of Cargill Texturizing Solutions’s alginates business, about the company’s announcement on 11 September that $15 million (£9.41 million) is to be spent on upgrading and expanding its alginates... more

17 Sep 2013 11:42 Editor's Blog

GEA Process Engineering will be exhibiting at ICSE/P-MEC to promote its GEA Niro pharmaceutical spray drying technology portfolio. Spray drying is rapidly becoming the technology of choice for pharmaceutical manufacturers that need fast... more

News

Aptalis Pharmaceutical Technologies is known for overcoming even the most demanding oral drug delivery challenges. The company’s comprehensive portfolio of oral drug delivery technologies for bioavailability enhancement, custom release profiles... more

News

Aesica Pharmaceuticals has announced the signing of an agreement between its subsidiary, Aesica Formulation Development Ltd, and QRxPharma Ltd for the global promotion of QRxPharma’s proprietary Stealth Beadlets abuse deterrence technology. more

Technology

Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma that focuses on developing patient-optimised oral products utilising its proprietary pharmaceutical technologies and development expertise, has announced its co-sponsorship of... more

Technology

To meet the increase in demand for Suglets sugar spheres, Colorcon is investing to increase capacity and reduce lead-time, thereby reducing customers’ supply risk while ensuring premium quality and consistent product. more

Technology